Throughout the development of anaesthesia, commencing with Morton and his inhaler, inventions and innovations have played a significant role. Whilst Morton's device was actually made by an anonymous glassblower, we can be reasonably sure that the design was Morton's own 1 .
John Snow was much more scientific, and his apparatus reflects a knowledge of respiratory physiology which was rare for his time. His drawover ether inhaler as replicated by A. Charles King 2 owes nothing to contemporary devices intended for delivery of various "therapeutic" vapours. In Britain, Clover's 3 , Hewitt's 4 and Probyn Williams' 5 inhalers, despite their popularity, were actually several steps backward in that they permitted by Commonwealth Industrial Gases such as the D-M Austox machine 14 , and an elegant expiratory valve attributed to him remains the most physiologically friendly device of its kind. He was also involved in designing the Australian Military Anaesthetic Machine of World War II 15, 16 .
As more Australian doctors specialized in anaesthesia, the number of original devices invented by Australians increased. John Stocks' suction bullet 17 , Noel Cass' needle, Bill Cole's pioneering agentspecific halothane vaporizer 18 and Harrison's brilliant lung simulator 19, 20 for evaluating ventilators are just a few of these.
Across the Tasman, John Ritchie devised the first practical oxygen failure alarm, and several useful breathing circuits such as the Palmerston system were produced there.
Two Australian anaesthetists with certain similarities in their backgrounds were responsible for remarkable technical achievements, but the outcomes have been very different. an unacceptable degree of rebreathing. Early in the twentieth century, Ivor Lewis designed an elegant anaesthetic machine 6 which was a marvel of portability. But for his premature death he might have been responsible for even more ingenious apparatus.
It is hardly surprising that in the nation which produced Morse, Edison and the Wright brothers, many outstanding devices were designed in America. In the decades between 1850 and the 1920s, the U.S.A. bred inventors by the thousand, and some were anaesthetists. Flagg 7 , Guedel 2 , Waters 9 , Heidbrink 10 , McKesson 11 … the list is long and the cast distinguished.
With its vast distances and small population principally involved in grazing and agriculture, most Australian ingenuity tended to concentrate on making farming easier and travel less time-consuming. Hence dependence on British, continental and American manufacturing industry was inevitable, especially in such specialized fields as medical equipment.
Little is known about anaesthetic apparatus of Australian design or manufacture before Bunny Lidwill's "cake-tin" ether machine 12 , although some attempts at nitrous oxide apparatus had been made by the "Safety" anaesthetic machine company in Sydney and J.B. Arnold 13 in Melbourne.
Geoffrey Kaye has no major apparatus named after him; in fact he disdained such notoriety. But he was extremely influential in the development of products He spent two years in that Department, but left without obtaining formal qualifications in anaesthesia although at this time with competent anaesthetists in very short supply, this was no immediate disadvantage. Grant's services were in demand, and he had no difficulty in obtaining work in both the public and private sectors.
Nevertheless his engineering background inexorably drew him back to technology, and in particular to the problem of safe and effective humidification, not only for anaesthesia in lengthy operations, but also in the expanding field of Intensive Care.
Grant's solutions to the problems of rain-out, thermal safety and consistent delivery of saturated gases to the airways were both original and effective 22 . A more serious problem was finding a means to commercially develop the technology. Unfortunately his prior connections to CIG were of no help, since they were wedded to their overseas partners at Puritan-Bennett and the parent company, BOC. Neither of these welcomed competition to their own humidifiers, despite their technical inferiority.
When a Victorian company with no track record in medical devices (albeit some experience of anaesthesia-related pharmaceuticals) showed interest, Grant had little choice but to entrust them with his brainchild. As (bad) luck would have it, a humidifier which achieved similar results by a different route which did not infringe Grant's patents was being developed in New Zealand, and it enjoyed two major advantages: endorsement by Matt Spence, and a vigorous, well-resourced company with excellent inhouse engineers 23 .
Without going into further detail, it is a matter of history that Fisher & Paykel's humidifier prevailed, and the Australian market was too small for two devices to share. Elegant and effective though it was, Grant's humidifier failed commercially.
David Komesaroff entered the University 24 . Many of those who read this classic study did not recognise that the victims had been subjected to many MAC hours of exposure, and that lower levels of administration are quite safe.
Komesaroff therefore undertook rehabilitation of this useful agent, first of all by designing a completely closed circuit system, loaded with a precisely calculated volume of methoxyflurane, sufficient to produce effective anaesthesia but falling well short of the threshold which could produce renal damage 25 .
But he was virtually on his own, and even though the system worked well, it was not taken up elsewhere. A very different outcome resulted from application of methoxyflurane as an analgesic, especially in the prehospital management of trauma and other painful conditions 26 .
Komesaroff's single-use inhaler 27 , charged with a fixed small volume of methoxyflurane immediately before use, has now been adopted by the Ambulance Service of Victoria and other authorities, displacing Entonox as the standard method of pain relief for casualties en route to hospital. It is also making its mark in emergency rooms, and for painful in-patient procedure such as burns dressings.
Anyone who has used methoxyflurane will recall its rather pungent aroma, reminiscent of a certain brand of chewing gum. To remove this nuisance from the closed environment of an ambulance, a charcoal filter has been developed which is now a standard accessory to the original inhaler.
When sourcing the agent threatened to become impossible as its original manufacturer abandoned production for commercial reasons, Komesaroff took the biggest risk of his life in setting up a facility which would comply with the extremely rigorous standards required of the present day pharmaceutical industry. This paper is not the place to examine that process in detail, but suffice it to say that for smallscale manufacture of a critical medication, it is an outstanding example of its kind.
Neither Grant nor Komesaroff are "historical", since at the time of writing they are both alive and in good health. Even more recently, Kevin Yee has been responsible for an invention of considerable promise. The concept of an inexpensive single-use laryngoscope is not new, and a partial solution was devised by the Welch Allyn company as far back as the 1970s. Its light source was a re-usable pencil-torch inside a cheap plastic housing. Light from the torch bulb is conducted along a Perspex pathway to the distal end of the Macintosh-type blade. It works well enough, but has the disadvantage of not being able to be sterilized intact, and the torch component relies on AA batteries which need to be checked.
Yee's solution 28 is to incorporate commercially available batteries which power an intense distal light source which is turned on by completing the circuit immediately prior to use. No switch is involved; and even more relevant to modern considerations of infection control, the entire apparatus is sterilised inside its sealed package.
One of the advantages of history is that it can be used (judiciously) to foretell the future. In these times when massive dominance of the industrial world is based in the Northern Hemisphere, with its enormous domestic markets, it is comforting to recognise that Australia and New Zealand are still capable of inventing and exploiting valuable new products for use in anaesthesia, intensive care and resuscitation.
